BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.
Open | $4.210 |
Close | - |
Volume / Avg. | 1.140M / 3.154M |
Day Range | 4.110 - 4.260 |
52 Wk Range | 4.030 - 9.065 |
Market Cap | $857.584M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 17.4% |
Days to Cover | 10.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioCryst Pharma (NASDAQ: BCRX) through any online brokerage.
Other companies in BioCryst Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for BioCryst Pharma (NASDAQ: BCRX) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 12.00 expecting BCRX to rise to within 12 months (a possible 185.71% upside). 13 analyst firms have reported ratings in the last year.
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $4.2 last updated Today at April 26, 2024 at 8:09 AM EDT.
There are no upcoming dividends for BioCryst Pharma.
BioCryst Pharma’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for BioCryst Pharma.
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.